Astria Therapeutics, Inc. (ATXS)
12.91
-0.06
(-0.46%)
USD |
NASDAQ |
Dec 11, 16:00
12.92
+0.01
(+0.08%)
After-Hours: 20:00
Astria Therapeutics Free Cash Flow: -120.32M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| BioCryst Pharmaceuticals, Inc. | 47.64M |
| Hologic, Inc. | 904.70M |
| Johnson & Johnson | 20.46B |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
| CorMedix, Inc. | 74.42M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -32.30M |
| Cash from Investing (Quarterly) | 52.25M |
| Cash from Financing (Quarterly) | 0.003M |
| Free Cash Flow Per Share (Quarterly) | -0.5568 |
| Free Cash Flow to Equity (Quarterly) | -31.99M |
| Free Cash Flow to Firm (Quarterly) | -32.30M |
| Free Cash Flow Yield | -16.18% |